标题
In vitro immunotherapy potency assays using real-time cell analysis
作者
关键词
Cytolysis, Apoptosis, Cancer immunotherapy, Flow cytometry, Raji cells, Antibodies, T cells, Immune cells
出版物
PLoS One
Volume 13, Issue 3, Pages e0193498
出版商
Public Library of Science (PLoS)
发表日期
2018-03-03
DOI
10.1371/journal.pone.0193498
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens
- (2017) Xuefeng Liu et al. Nature Protocols
- Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators
- (2017) Arthur Dyer et al. Molecular Therapy-Oncolytics
- Immunotherapy resistance: the answers lie ahead – not in front – of us
- (2017) Miles C. Andrews et al. Journal for ImmunoTherapy of Cancer
- PD-1 Pathway Inhibitors: Changing the Landscape of Cancer Immunotherapy
- (2017) Dawn E. Dolan et al. Cancer Control
- Avidity characterization of genetically engineered T-cells with novel and established approaches
- (2016) Victoria Hillerdal et al. BMC IMMUNOLOGY
- Cancer immunotherapy: the beginning of the end of cancer?
- (2016) Sofia Farkona et al. BMC Medicine
- Quantifying the Potency of Cancer Immunotherapies
- (2016) Brandon J. Lamarche et al. Genetic Engineering & Biotechnology News
- Harnessing T cells to fight cancer with BiTE®antibody constructs - past developments and future directions
- (2016) Matthias Klinger et al. IMMUNOLOGICAL REVIEWS
- Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape
- (2016) Meenakshi Hegde et al. JOURNAL OF CLINICAL INVESTIGATION
- Culture and Drug Profiling of Patient Derived Malignant Pleural Effusions for Personalized Cancer Medicine
- (2016) Christian Ruiz et al. PLoS One
- Lysosome-associated membrane glycoprotein 1 predicts fratricide amongst T cell receptor transgenic CD8+ T cells directed against tumor-associated antigens
- (2016) Andreas Kirschner et al. Oncotarget
- Favorable NK cell activity after haploidentical hematopoietic stem cell transplantation in stage IV relapsed Ewing’s sarcoma patients
- (2015) P Schlegel et al. BONE MARROW TRANSPLANTATION
- The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma
- (2015) Kathleen M. Mahoney et al. CLINICAL THERAPEUTICS
- Efficacy of systemic adoptive transfer immunotherapy targeting NY-ESO-1 for glioblastoma
- (2015) Richard G. Everson et al. NEURO-ONCOLOGY
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway
- (2015) Kim C. Ohaegbulam et al. TRENDS IN MOLECULAR MEDICINE
- New immunotherapies targeting the PD-1 pathway
- (2015) Jordan M. Chinai et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- CAR-T cells are serial killers
- (2015) Alexander J Davenport et al. OncoImmunology
- Novel Bispecific Antibodies Increase T-Cell Cytotoxicity against Pancreatic Cancer Cells
- (2014) H.-H. Oberg et al. CANCER RESEARCH
- An impedance-based cytotoxicity assay for real-time and label-free assessment of T-cell-mediated killing of adherent cells
- (2014) Janet Kerstin Peper et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Measuring Cytotoxicity by Bioluminescence Imaging Outperforms the Standard Chromium-51 Release Assay
- (2014) Mobin A. Karimi et al. PLoS One
- A simple in vitro method for evaluating dendritic cell-based vaccinations
- (2014) Phuc Pham et al. OncoTargets and Therapy
- PD-1 Blockade in Renal Cell Carcinoma: To Equilibrium and Beyond
- (2014) L. C. Harshman et al. Cancer Immunology Research
- γδ T Cell-Mediated Antibody-Dependent Cellular Cytotoxicity with CD19 Antibodies Assessed by an Impedance-Based Label-Free Real-Time Cytotoxicity Assay
- (2014) Ursula Jördis Eva Seidel et al. Frontiers in Immunology
- Characterization of Spontaneous and TGF-β-Induced Cell Motility of Primary Human Normal and Neoplastic Mammary Cells In Vitro Using Novel Real-Time Technology
- (2013) Katharina Mandel et al. PLoS One
- Regulation of immunotherapeutic products for cancer and FDA’s role in product development and clinical evaluation
- (2013) Ramjay S Vatsan et al. Journal for ImmunoTherapy of Cancer
- Reporter Gene Imaging of Immune Responses to Cancer: Progress and Challenges
- (2012) Purnima Dubey Theranostics
- ELISPOT Assay for Monitoring Cytotoxic T Lymphocytes (CTL) Activity in Cancer Vaccine Clinical Trials
- (2012) Anatoli M. Malyguine et al. Cells
- New flow cytometric assays for monitoring cell-mediated cytotoxicity
- (2010) Liubov Zaritskaya et al. Expert Review of Vaccines
- Cutting Edge: The Membrane Type Matrix Metalloproteinase MMP14 Mediates Constitutive Shedding of MHC Class I Chain-Related Molecule A Independent of A Disintegrin and Metalloproteinases
- (2010) G. Liu et al. JOURNAL OF IMMUNOLOGY
- A Simple and Sensitive Method for Measuring Tumor-Specific T Cell Cytotoxicity
- (2010) Xinping Fu et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started